STRUCTURE-ACTIVITY-RELATIONSHIPS FOR MITOMYCIN-C AND MITOMYCIN-A ANALOGS

被引:54
|
作者
KUNZ, KR
IYENGAR, BS
DORR, RT
ALBERTS, DS
REMERS, WA
机构
[1] UNIV ARIZONA,DEPT PHARMACEUT SCI,TUCSON,AZ 85721
[2] UNIV ARIZONA,CTR CANC,TUCSON,AZ 85721
关键词
PORFIROMYCIN ANALOGS; ANTITUMOR-ACTIVITY; SUBSTITUENTS; POSITION-7;
D O I
10.1021/jm00111a051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A set of 30 mitomycin C and mitomycin A analogues, including five new compounds, was screened against three different solid human tumor cell lines using the MTT tetrazolium dye assay. A statistically significant correlation among antitumor activity, quinone reduction potential (E1/2), and the logarithm of the partition coefficient (log P) was obtained, with the most easily reduced and the most lipophilic compounds being the most potent. When these analogues were separated into mitomycin C and mitomycin A subsets, the former gave a correlation only with E1/2, whereas the latter (which differ little in their E1/2 values) gave a correlation only with log P. These correlations are in contrast to those made in the P388 leukemia assay in mice wherein the most active mitomycin C and mitomycin A analogues were the most hydrophilic ones. When the same compounds were tested against P388 leukemia cells in the MTT assay, the results were the same as those of the solid tumor assays. Thus, the substantial differences in relative potencies of mitomycins are related not to the kind of tumor cell, but to the type of assay performed, cell culture versus whole animal. No correlation was found between antitumor potency in the cell culture systems and calculated relative DNA binding strengths, probably because the limiting factors in antitumor potency of mitomycins appear to be tumor cell uptake (log P) and/or bioreductive activation (E1/2).
引用
收藏
页码:2281 / 2286
页数:6
相关论文
共 50 条
  • [1] STRUCTURE-ACTIVITY COMPARISON OF MITOMYCIN-C AND MITOMYCIN-A ANALOGS - REVIEW
    BRADNER, WT
    REMERS, WA
    VYAS, DM
    ANTICANCER RESEARCH, 1989, 9 (04) : 1095 - 1099
  • [2] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL MITOMYCIN-C ANALOGS DERIVED FROM MITOMYCIN-A
    KURODA, T
    HISAMURA, K
    MATSUKUMA, I
    OSAWA, Y
    SUGAYA, T
    NISHIKAWA, H
    MORIMOTO, M
    ASHIZAWA, T
    NAKAMIZO, N
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1994, 31 (01) : 113 - 119
  • [3] CARDIOTOXICITY OF MITOMYCIN-A, MITOMYCIN-C, AND 7 N7 ANALOGS INVITRO
    DORR, RT
    SHIPP, NG
    LIDDIL, JD
    IYENGAR, BS
    KUNZ, KR
    REMERS, WA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (01) : 1 - 5
  • [4] ANTHELMINTIC ACTIVITY OF MITOMYCIN-A, MITOMYCIN-C, AND MITOMYCIN-F AGAINST HYMENOLEPIDID LARVAE IN TRIBOLIUM-CONFUSUM
    NOVAK, M
    KORNOVSKI, B
    KUNZ, KR
    CANADIAN JOURNAL OF ZOOLOGY-REVUE CANADIENNE DE ZOOLOGIE, 1991, 69 (06): : 1715 - 1717
  • [5] NEW MITOMYCIN-A ANALOGS
    SAMI, SM
    IYENGAR, BS
    REMERS, WA
    BRADNER, WT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 42 - MEDI
  • [6] SYNTHETIC STUDIES TOWARD MITOMYCINS .3. TOTAL SYNTHESES OF MITOMYCIN-A AND MITOMYCIN-C
    FUKUYAMA, T
    NAKATSUBO, F
    COCUZZA, AJ
    KISHI, Y
    TETRAHEDRON LETTERS, 1977, (49) : 4295 - 4298
  • [7] COMPARATIVE REACTIVITIES OF MITOMYCIN-C, 7-(N-PIPERIDINO)MITOMYCIN, AND MITOMYCIN-A - THE ROLE OF THE C(7) SUBSTITUENT
    SUBRAMANIAM, S
    KOHN, H
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (23) : 10519 - 10526
  • [8] PREPARATION AND ANTITUMOR-ACTIVITY OF NEW MITOMYCIN-A ANALOGS
    SAMI, SM
    IYENGAR, BS
    REMERS, WA
    BRADNER, WT
    JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (01) : 168 - 173
  • [9] PREPARATION AND ANTITUMOR-ACTIVITY OF ADDITIONAL MITOMYCIN-A ANALOGS
    SAMI, SM
    REMERS, WA
    BRADNER, WT
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) : 703 - 708
  • [10] SYNTHESIS OF CYCLOPENTANTHRAQUINONES - ANALOGS OF MITOMYCIN-C
    KOHLER, B
    SU, TL
    CHOU, TC
    JIANG, XJ
    WATANABE, KA
    JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (07): : 1680 - 1686